Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
Europe Nerve Repair & Regeneration Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Neurostimulation & Neuromodulation Devices and Biomaterials), and Application (Neurostimulation & Neuromodulation Applications , and Nerve Repair & Regeneration Applications )
- Report Code : BMIRE00027570
- Pages : 202
The nerve repair & regeneration market in Europe is expected to grow from US$ 1,537.23 million in 2022 to US$ 2,709.29 million by 2028; it is estimated to grow at a CAGR of 9.9% from 2022 to 2028.
Rising Prevalence of Age-associated Neurological Disorders among Geriatric Population Boosts Europe Nerve Repair & Regeneration Market Growth
Some neurologic disorders such as neuropathy, Alzheimer’s disease, Parkinson’s disease, and strokes are more common in the elderly, and their prevalence is increasing with higher life expectancies. According to the WHO, the population is aging rapidly worldwide. Between 2015 and 2050, the world’s population over 60 years will nearly double, from 12% to 22%, and mental and neurological disorders among older adults are likely to account for 6.6% of the total disability-adjusted life year (DALYs) for this age group. Also, as per the same source, approximately 15% of adults aged 60 and over have a mental disorder. The death rate due to neurological disorders is also increasing. For instance, according to the Alzheimer’s Association, 1 in 3 seniors dies with Alzheimer’s or dementia. Therefore, rising prevalence of age-associated neurological disorders increases demand for treatment of nerve repair & regeneration. This factor is propelling the growth of nerve repair & regeneration market.
Market Overview
The Europe nerve repair & regeneration market is further segmented into Germany, France, Italy, Spain, the UK, and the Rest of Europe. The Europe nerve repair & regeneration market growth is attributed to the growing geriatric population, increasing incidence of neurological disorders, high incidence of nerve injuries, and rising government support for neurological disorder studies. According to the German Alzheimer Society, in 2021, ~1.6 million people in Germany had dementia, and ~300,000 new cases are detected every year. Furthermore, the aging population is expected to increase from 2.4 in 2021 to 2.8 million by 2050, which is a major cause of dementia. Similarly, Parkinson’s disease is the second most common neurodegenerative disorder, which causes disability and movement disorder. According to Acta Neurologica Scandinavica, the number of people diagnosed with Parkinson’s disease will be doubled by 2050 in Europe. According to the German Society of Neurology, the prevalence of Parkinson’s disease is 1800 in every 100,000 persons. To control the growing prevalence of neurological disorders, the German Center for Neurodegenerative Diseases (DZNE) is investigating the major cause of nervous system diseases and various approaches for prevention, therapy, and care. Further, the DZNE, in collaboration with their university partners, promotes young researchers in studies of neurological disorders. Thus, the growing prevalence of neurological diseases and government-supported initiatives to combat the disease are driving the growth of the Europe nerve repair & regeneration market.
Europe Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (US$ Million)
Europe Nerve Repair & Regeneration Market Segmentation
The Europe nerve repair & regeneration market is bifurcated on the basis of product and application.
Based on product, the Europe nerve repair & regeneration market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment accounted for a larger market share in 2022. Based on application, the Europe nerve repair & regeneration market is bifurcated into neurostimulation & neuromodulation applications and nerve repair & regeneration applications. The nerve repair & regeneration applications segment held a larger market share in 2022. Based on country, the Europe nerve repair & regeneration market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Further, Germany dominated the market in 2022.
Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV are the leading companies operating in the nerve repair & regeneration market in Europe.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Nerve Repair & Regeneration Market – By Product
1.3.1.1 Neurostimulation and Neuromodulation Devices
1.3.1.2 Biomaterials
1.3.2 Europe Nerve Repair & Regeneration Market – By Application
1.3.2.1 Neurostimulation & Neuromodulation Applications
1.3.2.2 Nerve Repair & Regeneration Applications
1.3.3 Europe Nerve Repair & Regeneration Market – By Country
2. Europe Nerve Repair & Regeneration Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Nerve Repair & Regeneration Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. Europe Nerve Repair & Regeneration Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Extending Geriatric Population and Rising Prevalence of Age-Associated Neurological Disorders
5.1.2 Increasing Funding by Private and Government Organizations for Research in Neurology
5.2 Key Market Restraints
5.2.1 Dearth of trained professionals
5.3 Key Market Opportunities
5.3.1 Advancements in Stem Cell Therapy in Nerve Repair & Regeneration
5.4 Future Trend
5.4.1 Strengthening R&D Activities and Investment by Market Players
5.5 Impact analysis
6. Europe Nerve Repair & Regeneration Market Analysis
6.1 Europe Nerve Repair & Regeneration Market Revenue Forecast and Analysis
7. Europe Nerve Repair & Regeneration Market – by Product
7.1 Overview
7.2 By Product: Market Revenue and Forecast Analysis (US$ Million)
7.2.1 Neurostimulation and Neuromodulation Devices
7.2.1.1 Overview
7.2.1.2 Neurostimulation and Neuromodulation Devices Market Revenue and Forecast to 2028 (US$ Million)
7.2.1.3 Internal Neurostimulation Devices
7.2.1.3.1 Overview
7.2.1.3.2 Internal Neurostimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
7.2.1.3.3 Spinal Cord Stimulation
7.2.1.3.3.1 Overview
7.2.1.3.3.2 Spinal Cord Stimulation Market Revenue and Forecast to 2028 (US$ Million)
7.2.1.3.4 Deep Brain Stimulation
7.2.1.3.4.1 Overview
7.2.1.3.4.2 Deep Brain Stimulation Market Revenue and Forecast to 2028 (US$ Million)
7.2.1.3.5 Vagus Nerve Stimulation
7.2.1.3.5.1 Overview
7.2.1.3.5.2 Vagus Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Million)
7.2.1.3.6 Sacral Nerve Stimulation
7.2.1.3.6.1 Overview
7.2.1.3.6.2 Sacral Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Million)
7.2.1.3.7 Gastric Electrical Stimulation
7.2.1.3.7.1 Overview
7.2.1.3.7.2 Gastric Electrical Stimulation Market Revenue and Forecast to 2028 (US$ Million)
7.2.1.4 External Neurostimulation Devices
7.2.1.4.1 Overview
7.2.1.4.2 External Neurostimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
7.2.1.4.3 Transcutaneous Electrical Nerve Stimulation Devices
7.2.1.4.3.1 Overview
7.2.1.4.3.2 Transcutaneous Electrical Nerve Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
7.2.1.4.4 Transcranial Magnetic Stimulation Devices
7.2.1.4.4.1 Overview
7.2.1.4.4.2 Transcranial Magnetic Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
7.2.1.4.5 Respiratory Electrical Stimulation Devices
7.2.1.4.5.1 Overview
7.2.1.4.5.2 Respiratory Electrical Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
7.2.2 Biomaterials
7.2.2.1 Overview
7.2.2.2 Biomaterials Market Revenue and Forecast to 2028 (US$ Million)
7.2.2.3 Nerve conduits
7.2.2.3.1 Overview
7.2.2.4 Nerve wraps
7.2.2.4.1 Overview
7.2.2.4.2 Nerve wraps Market Revenue and Forecast to 2028 (US$ Million)
7.2.2.5 Nerve Connectors
7.2.2.5.1 Overview
7.2.2.5.2 Nerve Connectors Market Revenue and Forecast to 2028 (US$ Million)
7.2.2.6 Other Biomaterials
7.2.2.6.1 Overview
7.2.2.6.2 Other Biomaterials Market Revenue and Forecast to 2028 (US$ Million)
8. Europe Nerve Repair & Regeneration Market – by Application
8.1 Overview
8.2 By Application: Market Revenue and Forecast Analysis (US$ Million)
8.2.1 Neurostimulation & Neuromodulation applications
8.2.1.1 Overview
8.2.1.2 Neurostimulation & Neuromodulation applications Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.3 Internal neurostimulation and neuromodulation
8.2.1.3.1 Overview
8.2.1.3.2 Internal neurostimulation and neuromodulation Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.4 External neurostimulation and neuromodulation (LBL)
8.2.1.4.1 Overview
8.2.1.4.2 External neurostimulation and neuromodulation Market Revenue and Forecast to 2028 (US$ Million)
8.2.2 Nerve Repair & Regeneration Applications
8.2.2.1 Overview
8.2.2.2 Nerve Repair & Regeneration Applications Market Revenue and Forecast to 2028 (US$ Million)
8.2.2.3 Direct Nerve Repair/Neurorrhaphy
8.2.2.3.1 Overview
8.2.2.3.2 Direct Nerve Repair/Neurorrhaphy Market Revenue and Forecast to 2028 (US$ Million)
8.2.2.3.3 Epineural Repair
8.2.2.3.3.1 Overview
8.2.2.3.3.2 Epineural Repair Market Revenue and Forecast to 2028 (US$ Million)
8.2.2.3.4 Perineural Repair
8.2.2.3.4.1 Overview
8.2.2.3.4.2 Perineural Repair Market Revenue and Forecast to 2028 (US$ Million)
8.2.2.3.5 Group Fascicular Repair
8.2.2.3.5.1 Overview
8.2.2.3.5.2 Group Fascicular Repair Market Revenue and Forecast to 2028 (US$ Million)
8.2.2.4 Nerve Grafting
8.2.2.4.1 Overview
8.2.2.4.2 Nerve Grafting Market Revenue and Forecast to 2028 (US$ Million)
8.2.2.4.3 Autografts
8.2.2.4.3.1 Overview
8.2.2.4.3.2 Autografts Market Revenue and Forecast to 2028 (US$ Million)
8.2.2.4.4 Allografts
8.2.2.4.4.1 Overview
8.2.2.4.4.2 Allografts Market Revenue and Forecast to 2028 (US$ Million)
8.2.2.4.5 Xenografts
8.2.2.4.5.1 Overview
8.2.2.4.5.2 Xenografts Market Revenue and Forecast to 2028 (US$ Million)
8.2.2.5 Stem cell therapy
8.2.2.5.1 Overview
8.2.2.5.2 Stem cell therapy Market Revenue and Forecast to 2028 (US$ Million)
9. Europe Nerve Repair & Regeneration Market – Country Analysis
9.1 Overview
9.1.1 Europe: Nerve Repair & Regeneration Market, by Country, 2021 & 2028 (%)
9.1.1.1 Germany: Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.1 Overview
9.1.1.1.2 Germany: Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.3 Germany: Nerve Repair & Regeneration Market, by Product, 2019–2028 (US$ Million)
9.1.1.1.3.1 Germany: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices, 2019–2028 (US$ Million)
9.1.1.1.3.2 Germany: Nerve Repair & Regeneration Market, by Biomaterials, 2019–2028 (US$ Million)
9.1.1.1.4 Germany: Nerve Repair & Regeneration Market, by Application, 2019–2028 (US$ Million)
9.1.1.1.4.1 Germany: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications, 2019–2028 (US$ Million)
9.1.1.1.4.2 Germany: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications, 2019–2028 (US$ Million)
9.1.1.2 France: Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.1 Overview
9.1.1.2.2 France: Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.3 France: Nerve Repair & Regeneration Market, by Product, 2019–2028 (US$ Million)
9.1.1.2.3.1 France: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices, 2019–2028 (US$ Million)
9.1.1.2.3.2 France: Nerve Repair & Regeneration Market, by Biomaterials, 2019–2028 (US$ Million)
9.1.1.2.4 France: Nerve Repair & Regeneration Market, by Application, 2019–2028 (US$ Million)
9.1.1.2.4.1 France: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications, 2019–2028 (US$ Million)
9.1.1.2.4.2 France: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications, 2019–2028 (US$ Million)
9.1.1.3 Italy: Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.1 Overview
9.1.1.3.2 Italy: Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.3 Italy: Nerve Repair & Regeneration Market, by Product, 2019–2028 (US$ Million)
9.1.1.3.3.1 Italy: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices, 2019–2028 (US$ Million)
9.1.1.3.3.2 Italy: Nerve Repair & Regeneration Market, by Biomaterials, 2019–2028 (US$ Million)
9.1.1.3.4 Italy: Nerve Repair & Regeneration Market, by Application, 2019–2028 (US$ Million)
9.1.1.3.4.1 Italy: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications, 2019–2028 (US$ Million)
9.1.1.3.4.2 Italy: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications, 2019–2028 (US$ Million)
9.1.1.4 Spain: Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.1 Overview
9.1.1.4.2 Spain: Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.3 Spain: Nerve Repair & Regeneration Market, by Product, 2019–2028 (US$ Million)
9.1.1.4.3.1 Spain: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices, 2019–2028 (US$ Million)
9.1.1.4.3.2 Spain: Nerve Repair & Regeneration Market, by Biomaterials, 2019–2028 (US$ Million)
9.1.1.4.4 Spain: Nerve Repair & Regeneration Market, by Application, 2019–2028 (US$ Million)
9.1.1.4.4.1 Spain: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications, 2019–2028 (US$ Million)
9.1.1.4.4.2 Spain: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications, 2019–2028 (US$ Million)
9.1.1.5 United Kingdom: Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.1 Overview
9.1.1.5.2 United Kingdom: Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.3 United Kingdom: Nerve Repair & Regeneration Market, by Product, 2019–2028 (US$ Million)
9.1.1.5.3.1 United Kingdom: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices, 2019–2028 (US$ Million)
9.1.1.5.3.2 United Kingdom: Nerve Repair & Regeneration Market, by Biomaterials, 2019–2028 (US$ Million)
9.1.1.5.4 United Kingdom: Nerve Repair & Regeneration Market, by Application, 2019–2028 (US$ Million)
9.1.1.5.4.1 United Kingdom: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications, 2019–2028 (US$ Million)
9.1.1.5.4.2 United Kingdom: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications, 2019–2028 (US$ Million)
9.1.1.6 Rest of Europe: Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.1 Overview
9.1.1.6.2 Rest of Europe: Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.3 Rest of Europe: Nerve Repair & Regeneration Market, by Product, 2019–2028 (US$ Million)
9.1.1.6.3.1 Rest of Europe: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices, 2019–2028 (US$ Million)
9.1.1.6.3.2 Rest of Europe: Nerve Repair & Regeneration Market, by Biomaterials, 2019–2028 (US$ Million)
9.1.1.6.4 Rest of Europe: Nerve Repair & Regeneration Market, by Application, 2019–2028 (US$ Million)
9.1.1.6.4.1 Rest of Europe: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications, 2019–2028 (US$ Million)
9.1.1.6.4.2 Rest of Europe: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications, 2019–2028 (US$ Million)
10. Europe Nerve Repair & Regeneration Market – Industry Landscape
10.1 Overview
10.2 Inorganic Growth Strategies
10.2.1 Overview
10.3 Organic Growth Strategies
10.3.1 Overview
11. Company Profiles
11.1 Axogen Corporation
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Boston Scientific Corporation
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Integra LifeSciences
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Medtronic
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Abbott Laboratories
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Stryker Corporation
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Neuronetics
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 LivaNova PLC
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Baxter
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Polyganics BV
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
Table 1. Germany Nerve Repair & Regeneration Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany Nerve Repair & Regeneration Market, by Internal Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Nerve Repair & Regeneration Market, by External Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Nerve Repair & Regeneration Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications, 2019–2028 (US$ Million)
Table 7. Germany: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications, 2019–2028 (US$ Million)
Table 8. Germany: Nerve Repair & Regeneration Market, by Direct Nerve Repair/Neurorrhaphy, 2019–2028 (US$ Million)
Table 9. Germany: Nerve Repair & Regeneration Market, by Nerve Grafting, 2019–2028 (US$ Million)
Table 10. France Nerve Repair & Regeneration Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 11. France Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 12. France Nerve Repair & Regeneration Market, by Internal Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 13. France Nerve Repair & Regeneration Market, by External Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 14. France: Nerve Repair & Regeneration Market, by Biomaterials, 2019–2028 (US$ Million)
Table 15. France Nerve Repair & Regeneration Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. France: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications, 2019–2028 (US$ Million)
Table 17. France: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications, 2019–2028 (US$ Million)
Table 18. France: Nerve Repair & Regeneration Market, by Direct Nerve Repair/Neurorrhaphy, 2019–2028 (US$ Million)
Table 19. France: Nerve Repair & Regeneration Market, by Nerve Grafting, 2019–2028 (US$ Million)
Table 20. Italy Nerve Repair & Regeneration Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 21. Italy Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 22. Italy Nerve Repair & Regeneration Market, by Internal Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 23. Italy Nerve Repair & Regeneration Market, by External Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 24. Italy Nerve Repair & Regeneration Market, by Biomaterials – Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy Nerve Repair & Regeneration Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Applications – Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications – Revenue and Forecast to 2028 (US$ Million)
Table 28. Italy Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 29. Italy Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain Nerve Repair & Regeneration Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 31. Spain Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 32. Spain Nerve Repair & Regeneration Market, by Internal Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 33. Spain Nerve Repair & Regeneration Market, by External Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 34. Spain Nerve Repair & Regeneration Market, by Biomaterials – Revenue and Forecast to 2028 (US$ Million)
Table 35. Spain Nerve Repair & Regeneration Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 36. Spain Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Applications – Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications – Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain Nerve Repair & Regeneration Market, by Direct Nerve Repair/Neurorrhaphy – Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain Nerve Repair & Regeneration Market, by Nerve Grafting – Revenue and Forecast to 2028 (US$ Million)
Table 40. United Kingdom Nerve Repair & Regeneration Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 41. United Kingdom Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 42. United Kingdom Nerve Repair & Regeneration Market, by Internal Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 43. United Kingdom Nerve Repair & Regeneration Market, by External Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 44. United Kingdom Nerve Repair & Regeneration Market, by Biomaterials – Revenue and Forecast to 2028 (US$ Million)
Table 45. United Kingdom Nerve Repair & Regeneration Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 46. United Kingdom Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Applications – Revenue and Forecast to 2028 (US$ Million)
Table 47. United Kingdom Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications – Revenue and Forecast to 2028 (US$ Million)
Table 48. United Kingdom Nerve Repair & Regeneration Market, by Direct Nerve Repair/Neurorrhaphy – Revenue and Forecast to 2028 (US$ Million)
Table 49. United Kingdom Nerve Repair & Regeneration Market, by Nerve Grafting – Revenue and Forecast to 2028 (US$ Million)
Table 50. Rest of Europe Nerve Repair & Regeneration Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 51. Rest of Europe Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Europe Nerve Repair & Regeneration Market, by Internal Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Europe Nerve Repair & Regeneration Market, by External Neurostimulation devices – Revenue and Forecast to 2028 (US$ Million)
Table 54. Europe Nerve Repair & Regeneration Market, by Biomaterials – Revenue and Forecast to 2028 (US$ Million)
Table 55. Rest of Europe Nerve Repair & Regeneration Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 56. Rest of Europe Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Applications – Revenue and Forecast to 2028 (US$ Million)
Table 57. Europe Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications – Revenue and Forecast to 2028 (US$ Million)
Table 58. Europe Nerve Repair & Regeneration Market, by Direct Nerve Repair/Neurorrhaphy – Revenue and Forecast to 2028 (US$ Million)
Table 59. Rest of Europe Nerve Repair & Regeneration Market, by Nerve Grafting – Revenue and Forecast to 2028 (US$ Million)
Table 60. Recent Inorganic Growth Strategies in the Nerve Repair & Regeneration Market
Table 61. Recent Organic Growth Strategies in the Nerve Repair & Regeneration Market
Table 62. Glossary of Terms
Figure 1. Europe Nerve Repair & Regeneration Market Segmentation
Figure 2. Europe Nerve Repair & Regeneration Market – By Country
Figure 3. Europe Nerve Repair & Regeneration Market Overview
Figure 4. Table Top Nerve Repair & Regenerations Held Largest Share by Product of Nerve Repair & Regeneration Market
Figure 5. Germany to Show Significant Growth During Forecast Period
Figure 6. Europe Nerve Repair & Regeneration Market, Industry Landscape
Figure 7. Europe: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Europe Nerve Repair & Regeneration market impact analysis of driver and restraints
Figure 10. Europe Nerve Repair & Regeneration Market– Revenue Forecast and Analysis – 2020 – 2028
Figure 11. By Product: Market Analysis and Forecast 2021 and 2028 (%)
Figure 12. Neurostimulation and Neuromodulation Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. Internal Neurostimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Spinal Cord Stimulation Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. Deep Brain Stimulation Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. Vagus Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Million)
Figure 17. Sacral Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. Gastric Electrical Stimulation Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. External Neurostimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. Transcutaneous Electrical Nerve Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Transcranial Magnetic Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Respiratory Electrical Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Biomaterials Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Nerve conduits Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Nerve wraps Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. Nerve Connectors Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other Biomaterials Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. By Application: Market Analysis and Forecast 2021 and 2028 (%)
Figure 29. Neurostimulation & Neuromodulation applications Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. Internal neurostimulation and neuromodulation Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. External neurostimulation and neuromodulation Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. Nerve Repair & Regeneration Applications Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. Direct Nerve Repair/Neurorrhaphy Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. Epineural Repair Market Revenue and Forecast to 2028 (US$ Million)
Figure 35. Perineural Repair Market Revenue and Forecast to 2028 (US$ Million)
Figure 36. Group Fascicular Repair Market Revenue and Forecast to 2028 (US$ Million)
Figure 37. Nerve Grafting Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. Autografts Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. Allografts Market Revenue and Forecast to 2028 (US$ Million)
Figure 40. Xenografts Market Revenue and Forecast to 2028 (US$ Million)
Figure 41. Stem cell therapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 42. Europe: Nerve Repair & Regeneration Market, by Key Country – Revenue (2022) (US$ Million)
Figure 43. Germany Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (USD Million)
Figure 44. France Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (USD Million)
Figure 45. Italy Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (USD Million)
Figure 46. Spain Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (USD Million)
Figure 47. United Kingdom Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (USD Million)
Figure 48. Rest of Europe Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (USD Million)
● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe nerve repair & regeneration market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Europe nerve repair & regeneration market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the nerve repair & regeneration market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
● Axogen Corporation
● Boston Scientific Corporation
● Integra LifeSciences
● Medtronic
● Abbott Laboratories
● Stryker Corporation
● Neuronetics
● LivaNova PLC
● Baxter
● Polyganics BV
At 9.9% CAGR, the Europe Nerve Repair & Regeneration Market is speculated to be worth US$ 2,709.29 million by 2028, says The Insight Partners
According to The Insight Partners’ research, the Europe nerve repair & Regeneration Market was valued at US$ 1,537.23 million in 2022 and is expected to reach US$ 2,709.29 million by 2028, registering a CAGR of 9.9% from 2022 to 2028. Increasing funding by private and government organizations for research in neurology and extending geriatric population and rising prevalence of age-associated neurological disorders are factors boosting the market growth.
Patients with serious nerve injuries usually require lifelong assistance, which puts a huge burden on patients along with their families and society. Innovative, paradigm-shifting strategies are demanded to advance the treatment of the neurological injury. Scientists, engineers, clinicians, and other specialists in the across the region including Center for Regenerative Medicine are taking a multidisciplinary integrative approach to neuroregeneration for a number of devastating neurological conditions. Private and government organization are funding for the number of research projects going on in the field of nerve repair & regeneration, below are the few instances. In August 2022, Peripheral nerves are responsible for sensing temperatures, moving muscles, and inhaling and exhaling; yet they comprise fragile fibers susceptible to injury and disease. To magnify the healing of the easily damaged nerves, researchers from Penn State are using a five-year, US$ 2.14 million fund from the National Institute of Neurological Disorders and Stroke to develop a biodegradable nerve scaffold that seeks to employ citrate and folate in novel ways. In April 2020, Researchers at Albany Medical College were awarded a $ 1.9 million funding from the National Institute of Neurological Disorders and Stroke to study peripheral nerve repair. In March 2019, The Palaszczuk Government announced more than US$ 5 million to complete the first phase of a world-class ecotourism experience that’s listed to create 150 jobs and pump up to US$ 300 million into the economy of Tropical North Queensland economy. The funding increase more than doubles the Queensland Government’s investment in this project, which has already led to several promising outcomes relating to nerve repair around the spinal cord. Thus, increasing fundings by private and government organizations for research in neurology is contributing to the growth of nerve repair & regeneration market.
On the contrary, dearth of trained professionals is restraining the growth of the market.
Based on product type, the Europe nerve repair & regeneration market is segmented into neurostimulation and neuromodulation devices biomaterials. The neurostimulation segment held 64.9% market share in 2022, amassing US$ 997.25 million. It is projected to garner US$ 1,752.90 million by 2028 to expand at 9.9% CAGR during 2022–2028. Based on application, the Europe nerve repair & regeneration market is categorized into neurostimulation & neuromodulation applications and nerve repair & regeneration applications. The nerve repair & regeneration applications segment held 60.0% market share in 2022, amassing US$ 922.23 million. It is projected to garner US$ 1,612.86 million by 2028 to expand at 9.8% CAGR during 2022–2028. Based on country, the Europe nerve repair & Regeneration Market has been segmented into the Germany, the UK, France, Italy, Spain, and Rest of Europe. Our regional analysis states that Germany captured 23.7% market share in 2022. It was assessed at US$ 364.17 million in 2022 and is likely to hit US$ 636.96 million by 2028, exhibiting a CAGR of 9.8% during the forecast period. Key players dominating the Europe nerve repair & Regeneration Market are Axogen Corporation; Boston Scientific Corporation; Integra LifeSciences; Medtronic; Abbott Laboratories; Stryker Corporation; Neuronetics; LivaNova PLC; Baxter; and Polyganics BV among others.
Related Reports
- $3,000.00 – $5,000.00
